02187nas a2200301 4500000000100000008004100001653002200042653002100064653001300085653001500098653002300113653001300136653001400149653001100163653002400174100001500198700001500213700001200228700001700240700001200257700001500269245007100284856009800355300001000453490000600463520140200469022001401871 2014 d10aTropical Medicine10aTropical Climate10aResearch10aPrevalence10aNeglected Diseases10aMycetoma10aIncidence10aHumans10aBiomedical Research1 aSande WW J1 aMaghoub ES1 aFahal A1 aGoodfellow M1 aWelsh O1 aZijlstra E00aThe mycetoma knowledge gap: identification of research priorities. uhttp://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002667&type=printable ae26670 v83 a

Mycetoma is a tropical disease which is caused by a taxonomically diverse range of actinomycetes (actinomycetoma) and fungi (eumycetoma). The disease was only recently listed by the World Health Organization (WHO) as a neglected tropical disease (NTD). This recognition is the direct result of a meeting held in Geneva on February 1, 2013, in which experts on the disease from around the world met to identify the key research priorities needed to combat mycetoma. The areas that need to be addressed are highlighted here. The initial priority is to establish the incidence and prevalence of the disease in regions where mycetoma is endemic, prior to determining the primary reservoirs of the predominant causal agents and their mode of transmission to susceptible individuals in order to establish novel interventions that will reduce the impact of the disease on individuals, families, and communities. Critically, economical, reliable, and effective methods are required to achieve early diagnosis of infections and consequential improved therapeutic outcomes. Molecular techniques and serological assays were considered the most promising in the development of novel diagnostic tools to be used in endemic settings. Improved strategies for treating eumycetoma and actinomycetoma are also considered.

 

 

 

 

 

 a1935-2735